Reuters logo
BRIEF-Medigus receives approval to conduct multi-center muse clinical study in China
February 16, 2017 / 12:15 PM / in 10 months

BRIEF-Medigus receives approval to conduct multi-center muse clinical study in China

Feb 16 (Reuters) - Medigus Ltd -

* Medigus receives approval for commencement of the first multi-center muse clinical study from cfda in China

* Procedures are expected to start in march and carry on through 2017, with results being reported to cfda in 2018 from muse clinical study Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below